{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T22:26:12Z","timestamp":1750112772912},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"2-3","license":[{"start":{"date-parts":[[1976,6,1]],"date-time":"1976-06-01T00:00:00Z","timestamp":202435200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch. F. Psychiatr. U. Z. Neur."],"published-print":{"date-parts":[[1976,6]]},"DOI":"10.1007\/bf02206619","type":"journal-article","created":{"date-parts":[[2005,10,5]],"date-time":"2005-10-05T18:49:01Z","timestamp":1128538141000},"page":"223-243","source":"Crossref","is-referenced-by-count":17,"title":["Wirkung des Beta-Rezeptoren-Blockers Propranolol auf Manien"],"prefix":"10.1007","volume":"222","author":[{"given":"W.","family":"Rackensperger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Fritsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. H.","family":"Stutte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Zerssen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02206619_CR1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF00426104","volume":"38","author":"N.-E. Anden","year":"1974","unstructured":"Anden, N.-E., Str\u00f6mbom, U.: Adrenergic receptor blocking agents: effects on central noradrenaline and dopamine receptors and on motor activity. Psychopharmacologia (Berl.) 38, 91\u2013103 (1974)","journal-title":"Psychopharmacologia (Berl.)"},{"key":"BF02206619_CR2","doi-asserted-by":"crossref","unstructured":"Atsmon, A., Blum, J.: Treatment of acute porphyria variegata with propranolol. Lancet 1970, 196\u2013197","DOI":"10.1016\/S0140-6736(70)90447-2"},{"key":"BF02206619_CR3","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/BF00422805","volume":"27","author":"A. Atsmon","year":"1972","unstructured":"Atsmon, A., Blum, J., Steiner, M., Latz, A.; Wijsenbeek, H.: Further studies with propranolol in psychotic patients. Psychopharmacologia (Berl.) 27, 249\u2013254 (1972)","journal-title":"Psychopharmacologia (Berl.)"},{"key":"BF02206619_CR4","first-page":"251","volume":"74","author":"A. Atsmon","year":"1971","unstructured":"Atsmon, A., Blum, J., Wijsenbeek, H., Maoz, B., Steiner, M., Ziegelman, G.: The short-term effect of adrenergic blocking agents in a small group of psychotic patients. Psychiat. Neurol. Neurochir. (Amst.) 74, 251\u2013258 (1971)","journal-title":"Psychiat. Neurol. Neurochir. (Amst.)"},{"key":"BF02206619_CR5","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/BF00578032","volume":"6","author":"K. Behrends","year":"1971","unstructured":"Behrends, K., Flegel, H., Helmchen, H., Hippius, H., H\u00f6ffken, K. D., Schacht, L., Schulte, P. W.: Quantifizierung psychotischer Symptome unter transkulturellen Aspekten. Soc. Psychiat. 6, 66\u201372 (1971)","journal-title":"Soc. Psychiat."},{"key":"BF02206619_CR6","unstructured":"Bender, W.: Studie zur Reliabilit\u00e4t und differentiellen Validit\u00e4t der Lorr-Skala (IMPS). Med. Diss., Univ. Hamburg 1974"},{"key":"BF02206619_CR7","volume-title":"Beta-blockers \u2014 present status and future prospects","author":"E. K. Chung","year":"1974","unstructured":"Chung, E. K.: Beta-blockers in the treatment of disturbances in cardiac rhythm. In: Schweizer W. (ed.): Beta-blockers \u2014 present status and future prospects. Bern, Stuttgart, Vienna: H. Huber 1974"},{"key":"BF02206619_CR8","first-page":"314","volume":"15","author":"G. Gardos","year":"1973","unstructured":"Gardos, G., Cole, J. O., Volicer, L., Orzack, M., Oliff, A. C.: A dose-response study of propranolol in chronic schizophrenics. Curr. ther. Res. 15, 314\u2013323 (1973)","journal-title":"Curr. ther. Res."},{"key":"BF02206619_CR9","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/231453a0","volume":"231","author":"H. W. Goldman","year":"1971","unstructured":"Goldman, H. W., Lehr, D., Friedman, E.: Antagonistic effects of alpha and beta adrenergically coded hypothalamic neurons on consummatory behaviour in the rat. Nature (Lond.) 231, 453\u2013455 (1971)","journal-title":"Nature (Lond.)"},{"key":"BF02206619_CR10","doi-asserted-by":"crossref","first-page":"118","DOI":"10.2165\/00003495-197407010-00008","volume":"7","author":"D. J. Greenblatt","year":"1974","unstructured":"Greenblatt, D. J., Koch-Weser, J.: Adverse reactions to \u03b2-adrenergic receptor blocking drugs: A report from the Boston Collaborative Drug Surveillance Program. Drugs 7, 118\u2013129 (1974)","journal-title":"Drugs"},{"key":"BF02206619_CR11","first-page":"615","volume":"14","author":"D. J. Greenblatt","year":"1972","unstructured":"Greenblatt, D. J., Shader, R. I.: On the psychopharmacology of beta-adrenergic blockade. Curr. ther. Res. 14, 615\u2013625 (1972)","journal-title":"Curr. ther. Res."},{"key":"BF02206619_CR12","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1136\/bmj.2.5654.445","volume":"2","author":"R. D. Hinshelwood","year":"1969","unstructured":"Hinshelwood, R. D.: Hallucinations and propranolol. Brit. Med. J. 2, 445 (1969)","journal-title":"Brit. Med. J."},{"key":"BF02206619_CR13","unstructured":"Honigfeld, G.: NOSIE-30, History and current status of its use in pharmacopsychiatric research. In: Psychological measurements in psychopharmacology. Mod. Probl. Pharmacopsychiat. Vol. 7, 238\u2013263 (1974)"},{"key":"BF02206619_CR14","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/1097-4679(196501)21:1<65::AID-JCLP2270210122>3.0.CO;2-I","volume":"21","author":"G. Honigfeld","year":"1965","unstructured":"Honigfeld, G., Klett, C. J.: The nurses' observation scale for inpatient evaluation. A new ward behavior rating scale. J. clin. Psychol. 21, 65\u201371 (1965)","journal-title":"J. clin. Psychol."},{"key":"BF02206619_CR15","unstructured":"Jacobi, P.: Untersuchungen zur Faktorenstruktur, Zuverl\u00e4ssigkeit und G\u00fcltigkeit einer deutschen Bearbeitung der IMPS nach Lorr. Med. Diss., Univ. Hamburg 1974"},{"key":"BF02206619_CR16","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1001\/archpsyc.1974.01760170071012","volume":"31","author":"J. W. Jefferson","year":"1974","unstructured":"Jefferson, J. W.: Beta-adrenergic receptor blocking drugs in psychiatry. Arch. Gen. Psychiat. 31, 681\u2013691 (1974)","journal-title":"Arch. Gen. Psychiat."},{"key":"BF02206619_CR17","first-page":"987","volume":"62","author":"M. F. Keller","year":"1973","unstructured":"Keller, M. F.: Nebenwirkungen, Kontraindikationen und antagonistische Ma\u00dfnahmen bei der Anwendung von Beta-Rezeptoren-Blockern (BRB) Schweiz. Rundschau Med. 62, 987\u2013991 (1973)","journal-title":"Rundschau Med."},{"key":"BF02206619_CR18","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF00421921","volume":"26","author":"P. A. Kral","year":"1972","unstructured":"Kral, P. A., Omer, V. V. St.: Beta-adrenergic receptor involvement in the mediation of learned taste aversions. Psychopharmacologia (Berl.) 26, 79\u201383 (1972)","journal-title":"Psychopharmacologia (Berl.)"},{"key":"BF02206619_CR19","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/226963a0","volume":"226","author":"S. F. Leibowitz","year":"1970","unstructured":"Leibowitz, S. F.: Hypothalamic beta-adrenergic satiety system antagonizes an alpha-adrenergic hunger system in the rat. Nature (Lond.) 226, 963\u2013964 (1970)","journal-title":"Nature (Lond.)"},{"key":"BF02206619_CR20","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1055\/s-0028-1094401","volume":"7","author":"M. Lorr","year":"1974","unstructured":"Lorr, M.: Assessing psychotic behaviour by the IMPS. Mod. Probl. Pharmacopsychiat. 7, 50\u201363 (1974)","journal-title":"Mod. Probl. Pharmacopsychiat."},{"key":"BF02206619_CR21","volume-title":"Inpatient multi-dimensional psychiatric scale","author":"M. Lorr","year":"1963","unstructured":"Lorr, M., Klett, C. J., McNair, D. M., Lasky, J. J.: Inpatient multi-dimensional psychiatric scale. Manual. Palo Alto\/Calif.: Psychological Press 1963. (Deutsch: Multidimensionale psychiatrische Skala f\u00fcr Klinikpatienten von Maurice Lorr, Douglas M. McNair, C. James Klett und Julian J. Lasky, \u00fcbers. von H. Flegel und Margarete M\u00e4der)"},{"key":"BF02206619_CR22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1037\/h0030008","volume":"73","author":"D. L. Margules","year":"1970","unstructured":"Margules, D. L.: Beta-adrenergic receptors in the hypothalamus for learned and unlearned taste aversions. J. Comp. Physiol. Psychol. 73, 13\u201321 (1970)","journal-title":"J. Comp. Physiol. Psychol."},{"key":"BF02206619_CR23","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0014-2999(71)90052-5","volume":"16","author":"D. L. Margules","year":"1971","unstructured":"Margules, D. L.: Alpha- and beta-adrenergic receptors in amygdala: reciprocal inhibitors and facilitators of punished operant behaviour. Europ. J. Pharmacol. 16, 21\u201326 (1971)","journal-title":"Europ. J. Pharmacol."},{"key":"BF02206619_CR24","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1600-0773.1967.tb00413.x","volume":"25","author":"D. Masuoka","year":"1967","unstructured":"Masuoka, D., Hansson, E.: Autoradiographic distribution studies of adrenergic blocking agents. II 1-propranolol, a beta-receptor-type blocker. Acta Pharmacol. Toxicol. 25, 447\u2013455 (1967)","journal-title":"Acta Pharmacol. Toxicol."},{"key":"BF02206619_CR25","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/BF01245319","volume":"33","author":"N. Matussek","year":"1972","unstructured":"Matussek, N.: Biochemie der Depression. J. neural Transmission 33, 223\u2013234 (1972)","journal-title":"J. neural Transmission"},{"key":"BF02206619_CR26","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/BF00343604","volume":"219","author":"W. Mombour","year":"1974","unstructured":"Mombour, W.: Syndrome bei psychiatrischen Erkrankungen. Eine vergleichende Untersuchung mit Hilfe von zwei Sch\u00e4tzskalen f\u00fcr den psychopathologischen Befund (IMPS und AMP-Skala). Arch. Psychiat. Nervenkr. 219, 331\u2013350 (1974)","journal-title":"Arch. Psychiat. Nervenkr."},{"key":"BF02206619_CR27","first-page":"352","volume":"44","author":"W. Mombour","year":"1973","unstructured":"Mombour, W., Gammel, G., Heyse, H., v. Zerssen, D.: Die Objektivierung psychiatrischer Syndrome durch multifaktorielle Analyse des psychopathologischen Befundes. Nervenarzt 44, 352\u2013358 (1973)","journal-title":"Nervenarzt"},{"key":"BF02206619_CR28","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/BF00429277","volume":"29","author":"M. H. Orzack","year":"1973","unstructured":"Orzack, M. H., Branconnier, R., Gardos G.: CNS effects of Propranolol in man. Psychopharmacologia (Berl.) 29, 299\u2013306 (1973)","journal-title":"Psychopharmacologia (Berl.)"},{"key":"BF02206619_CR29","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF00342993","volume":"219","author":"W. Rackensperger","year":"1974","unstructured":"Rackensperger, W., Gaupp, R., Mattke, D. J., Schwarz, D., Stutte, K. H.: Behandlung von akuten schizophrenen Psychosen mit Beta-Rezeptoren-Blockern. Arch. Psychiat. Nervenkr. 219, 29\u201336 (1974)","journal-title":"Arch. Psychiat. Nervenkr."},{"key":"BF02206619_CR30","first-page":"394","volume":"188","author":"J. L. Reid","year":"1974","unstructured":"Reid, J. L., Lewis, P. J., Myers, M. G., Dollery, C. T.: Cardiovascular effects of intracerebro-ventricular d-, l-, and d l-propranolol in the conscious rabbit. J. Pharmacol. Exp. Ther. 188, 394\u2013399 (1974)","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BF02206619_CR31","first-page":"86","volume":"188","author":"D. A. Saelens","year":"1974","unstructured":"Saelens, D. A., Walle, T., Privitera, P. J., Knapp, D. R., Gaffney, T.: Central nervous system effects and metabolic disposition of a glycol metabolite of propranolol. J. Pharmacol. Exp. Ther. 188, 86\u201392 (1974)","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BF02206619_CR32","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1176\/ajp.122.5.509","volume":"122","author":"J. J. Schildkraut","year":"1965","unstructured":"Schildkraut, J. J.: The catecholamine hypothesis of affective disorders; A review of supporting evidence. Amer. J. Psychiat. 122, 509\u2013522 (1965)","journal-title":"Amer. J. Psychiat."},{"key":"BF02206619_CR33","first-page":"397","volume":"45","author":"M. Schou","year":"1974","unstructured":"Schou, M.: Heutiger Stand der Rezidivprophylaxe bei endogenen affektiven Erkrankungen. Nervenarzt 45, 397\u2013418 (1974)","journal-title":"Nervenarzt"},{"key":"BF02206619_CR34","volume-title":"Kardiale Sympathikolyse als therapeutisches Prinzip","author":"D. Schwarz","year":"1975","unstructured":"Schwarz, D.: Die Anwendung von Beta-Rezeptoren-Blockern in Neurologie und Psychiatrie. In: Lydtin, H. und Meesmann, W. (Hrsg.): Kardiale Sympathikolyse als therapeutisches Prinzip. Stuttgart, Georg Thieme 1975"},{"key":"BF02206619_CR35","first-page":"648","volume":"44","author":"D. Schwarz","year":"1973","unstructured":"Schwarz. D., Mertin, J.: Die Anwendung von Propranolol bei der akuten intermittierenden Porphyrie. Nervenarzt 44, 648\u2013651 (1973)","journal-title":"Nervenarzt"},{"key":"BF02206619_CR36","unstructured":"Steiner, M., Blum, I., Wijsenbeek, H., Atsmon, A.: Results of the treatment of psychoses with propranolol. Kupat Holim Yearbook, 2, 1972"},{"key":"BF02206619_CR37","first-page":"421","volume":"76","author":"M. Steiner","year":"1973","unstructured":"Steiner, M., Latz, A., Blum, J., Atsmon, A., Wijsenbeek, H.: Propranolol versus chlorpromazine in the treatment of psychoses associated with childbearing. Psychiat. Neurol. Neurochir. (Amst.) 76, 421\u2013426 (1973)","journal-title":"Psychiat. Neurol. Neurochir. (Amst.)"},{"key":"BF02206619_CR38","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/0002-9149(66)90071-3","volume":"18","author":"S. A. Stephen","year":"1966","unstructured":"Stephen, S. A.: Unwanted effects of propranolol. Amer. J. Cardiol. 18, 463\u2013472 (1966)","journal-title":"Amer. J. Cardiol."},{"key":"BF02206619_CR39","first-page":"491","volume":"43","author":"W. Volk","year":"1972","unstructured":"Volk, W., Bier, W., Braun, J. P., Gr\u00fcter, W., Spiegelberg, U.: Behandlung von erregten Psychosen mit einem Beta-Rezeptoren-Blocker (Oxprenolol) in hoher Dosierung. Nervenarzt 43, 491\u2013492 (1972)","journal-title":"Nervenarzt"},{"key":"BF02206619_CR40","volume-title":"Kardiale Sympathikolyse als therapeutisches Prinzip","author":"W. Volk","year":"1975","unstructured":"Volk, W., Bier, W., Braun, J. P., Spiegelberg, U.: Klinische Beobachtungen bei hochdosierter Behandlung endogener Psychosen mit einem Beta-Rezeptorenblocker. In: Lydtin, H. u. Meesmann, W. (Hrsg.): Kardiale Sympathikolyse als therapeutisches Prinzip. Stuttgart: Georg Thieme 1975"},{"key":"BF02206619_CR41","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3109\/15563657108990486","volume":"4","author":"E. J. Voltolina","year":"1971","unstructured":"Voltolina, E. J., Thompson, S. I., Tisue, J.: Acute organic brain syndrome with propranolol. Clin. Toxicol. 4, 357\u2013361 (1971)","journal-title":"Clin. Toxicol."},{"key":"BF02206619_CR42","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1136\/bmj.4.5945.633","volume":"4","author":"N. J. Yorkston","year":"1974","unstructured":"Yorkston, N. J., Zaki, S. A., Malik, M. K., Morrison, R. C., Havard, C. W. H.: Propranolol in the control of schizophrenic symptoms. Brit. med. J. 4, 633\u2013635 (1974)","journal-title":"Brit. med. J."},{"key":"BF02206619_CR43","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0002-8703(72)90206-2","volume":"83","author":"F. J. Zacharias","year":"1972","unstructured":"Zacharias, F. J., Cowen, K. J., Prestt, J., Vickers, J., Wall, B. G.: Propranolol in hypertension: A study of long-term therapy, 1964\u20131970. Amer. Heart J. 83, 755\u2013761 (1972)","journal-title":"Amer. Heart J."},{"key":"BF02206619_CR44","unstructured":"Zerssen, D. v.: Beta-Adrenergic Blocking Agents in the Treatment of Psychoses. A Report on 17 Cases. In: C. Carlsson, J. Engel and L. Hansson (Eds.): CNS-Symposion Copenhagen 1975. Suppl. ad J. clin. Pharmacol. (1976)"}],"container-title":["Archiv f\u00fcr Psychiatrie und Nervenkrankheiten"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02206619.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02206619\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02206619","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T14:35:25Z","timestamp":1557844525000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02206619"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1976,6]]},"references-count":44,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[1976,6]]}},"alternative-id":["BF02206619"],"URL":"https:\/\/doi.org\/10.1007\/bf02206619","relation":{},"ISSN":["0003-9373","1433-8491"],"issn-type":[{"value":"0003-9373","type":"print"},{"value":"1433-8491","type":"electronic"}],"subject":[],"published":{"date-parts":[[1976,6]]}}}